- Home
- GMS vs RNA Comparison
GMS vs RNA Comparison
Compare GMS & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GMS
- RNA
- Stock Information
- Founded
- GMS 1971
- RNA 2012
- Country
- GMS United States
- RNA United States
- Employees
- GMS N/A
- RNA N/A
- Industry
- GMS
- RNA Biotechnology: Pharmaceutical Preparations
- Sector
- GMS
- RNA Health Care
- Exchange
- GMS Nasdaq
- RNA Nasdaq
- Market Cap
- GMS 3.2B
- RNA 3.7B
- IPO Year
- GMS 2016
- RNA 2020
- Fundamental
- Price
- GMS $78.24
- RNA $31.12
- Analyst Decision
- GMS Hold
- RNA Strong Buy
- Analyst Count
- GMS 7
- RNA 10
- Target Price
- GMS $93.57
- RNA $65.80
- AVG Volume (30 Days)
- GMS 306.9K
- RNA 1.3M
- Earning Date
- GMS 03-06-2025
- RNA 03-07-2025
- Dividend Yield
- GMS N/A
- RNA N/A
- EPS Growth
- GMS N/A
- RNA N/A
- EPS
- GMS 5.45
- RNA N/A
- Revenue
- GMS $5,590,609,000.00
- RNA $10,117,000.00
- Revenue This Year
- GMS $3.58
- RNA N/A
- Revenue Next Year
- GMS $2.88
- RNA N/A
- P/E Ratio
- GMS $14.97
- RNA N/A
- Revenue Growth
- GMS 4.12
- RNA N/A
- 52 Week Low
- GMS $77.29
- RNA $13.73
- 52 Week High
- GMS $105.54
- RNA $56.00
- Technical
- Relative Strength Index (RSI)
- GMS 27.08
- RNA 44.06
- Support Level
- GMS $82.60
- RNA $31.14
- Resistance Level
- GMS $84.64
- RNA $33.37
- Average True Range (ATR)
- GMS 1.75
- RNA 1.67
- MACD
- GMS -0.33
- RNA -0.16
- Stochastic Oscillator
- GMS 3.84
- RNA 11.27
About GMS GMS Inc.
GMS Inc is a distributor of specialty building products including wallboard, suspended ceiling systems, ceilings, steel framing, and other complementary building products. The company serves its products to commercial new construction, commercial repair and remodel, residential new construction, and residential repair and remodel (R&R). Its geographical segment is Central, Midwest, New York, Northeast, Southern, Southeast, Southwest, Western and Canada, and Ames. The company generates maximum revenue from Wallboard products.
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product, AOC 1001, is designed to treat a rare monogenic muscle disease.